ADMA Biologics
Dr. Kwon has been a director of ADMA since October 2021. He is Chief Financial and Operating Officer at Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies in neurodegeneration and oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ADMA Biologics
3 followers
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.